Canada ejects Chinese Scientist who discovered Ebola Vaccine in Canada
Canada’s 2018 Governor General’s Innovation Award laureate Evicted
Dr. Xiangguo Qiu, Canada’s 2018 Governor General’s Innovation Award laureate has been evicted from the Winnipeg National Microbiology Lab associated with the Canadian Department of Health & the University of Manitoba. This is suspected as a retaliation for China’s Canada Day week arrest of a drug dealer from Canada. Canada has been in a tit-for-tat diplomatic war with China since it kidnapped Meng Wanzhou, the Chief Financial Officer of Huawei Technologies which is the leading technology company in the 5G telecom revolution.
by Micheal John
In a series of tit-for-tat retaliations with China, Canada has responded to yet another Canadian arrested in China during a drug bust, by ejecting a Chinese scientist, her husband and her Chinese Students from a Winnipeg University bio-lab. During attempts to contact the Doctor, FPMag was told “don’t even try.
Read if you wish: Trudeau with Trump Goading China to World War [Analysis]
Following the drug arrest of a Canadian Citizen on Canada Day in Yantai in the province of Shandong, China, Canada has retaliated by ejecting a Chinese scientist and her students from a Winnipeg laboratory connected to the University of Manitoba and the Canadian Department of Health where her work included immunization against rare communicable disease.
Canada has removed from its only level-4 lab a famous scientist who has created a vaccine for EBola.
Dr. Xiangguo Qiu, her husband, and her students from China were also removed from the University of Manitoba teaching and research laboratory.
Dr. Xiangguo Qiu
Adjunct Professor, Department of Medical Microbiology, University of Manitoba
Head, Serology Diagnostic Unit, Special Pathogens Program, National Microbiology Laboratory
- M. D. (Hebei Medical University, China 1985),
- MSc (Tianjin Medical University, 1990)
For a recent list of publications from Dr. Qiu please click here. .
1. Wong G, Richardson J, Cutts T, Qiu X and Kobinger GP. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals. Antiviral Res. 2015 Jan 14;116C:17-19. doi: 10.1016/j.antiviral.2015.01.001. [Epub ahead of print]
2. Chowell D, Castillo-Chavez C, Krishna S, Qiu X and Anderson KS. Predicting the impact of detecting pre-symptomatic Ebola infections on the transmission dynamics of the 2014 West African outbreak. The Lancet Infectious Disease Vol 15 February 2015
3. Choi JH, Jonsson-Schmmunk K, Qiu X, Shedlock D, et al. A Single Dose Mucosal Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection. Molecular Pharmaceutics. 2014 Nov 1. [Epub ahead of print] DOI: 10.1021/mp500646d
4. Wong G, Qiu X, Richardson J, Cutts T, et al. Ebola virus transmission in guinea pigs. J Virol. 2014 Nov 12. pii: JVI.02836-14. [Epub ahead of print]
5. Murin DM, Fusco ML, Bornholdt ZA, Qiu X, et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus.. Proc Natl Acad Sci U S A. 2014 Nov 17. pii: 201414164. [Epub ahead of print]
6. Audet J, Wong G, Wang H, Lu G, Gao GF, Kobinger GP and Qiu X. Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus. Sci Rep. 2014 Nov 6; 4:6881. doi: 10.1038/srep06881.
7. Wiliams K, Qiu X, Fernando L, Steven JM and Alimonti J. VSVG/EBOV GP-induced Innate Protection Enhances NK Cell Activity to Increase Survival in a Lethal MA-EBOV Infection. Viral Immunol. 2014 Dec 10. [Epub ahead of print]
8. de La Vega M, Wong G, Kobinger GK and Qiu X. The Multiple Roles of sGP in Ebola Pathogenesis. Viral Immunol. 2014 Oct 29. [Epub ahead of print]
9. Qiu X, Wong G, et al Reversion of advanced Ebola virus disease in nonhuman primates treated with ZMappTM. Nature. 2014 Aug 29. doi:10.1038/nature13777. [Epub ahead of print]
10. Wong G, Audet J, Fernando L, Fauster-Bovendo H, Alimonti JB, Kobinger GP and Qiu X. Immunization with vesicular stomatitis vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine. 32 (2014) 5722-5729